Lipid profile in Egyptian patients with coronary artery disease

被引:12
|
作者
Ibrahim, M. Mohsen [1 ]
Ibrahim, Ahmed [2 ]
Shaheen, Khaldoon [2 ]
Nour, Mona A. [3 ]
机构
[1] Cairo Univ, Fac Med, Cardiol Dept, Giza, Egypt
[2] Case Western Reserve Univ, St Vincent Char Hosp, Cleveland, OH 44106 USA
[3] Cairo Univ, Trop Med Dept, Fac Med, Giza, Egypt
来源
EGYPTIAN HEART JOURNAL | 2013年 / 65卷 / 02期
关键词
Lipid profile; Coronary disease; Risk factors; Egypt;
D O I
10.1016/j.ehj.2012.08.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: No data are available about plasma lipid profile in Egyptians with coronary artery disease (CAD). Plasma lipid profile may differ according to ethnic origin and geographic area. Objectives: Identify plasma lipid abnormalities in Egyptians with CAD and define the role of age, type of CAD, and the presence of hypertension (HT) on lipid profile. Methods: Retrospective consecutive sampling of lipid profile of 1000 patients with CAD. Results were compared to a control group of 1920 non-coronary individuals. Results: Patients' age range was 19-90 years. HT was present in 56.7% of patients. The commonest isolated lipid abnormality was a reduced HDL-C in men and increased plasma triglycerides (TG) in women. Patients with myocardial infarction (MI) had a lower HDL-C than those with angina pectoris (AP). Abnormalities were more severe and more prevalent in the young age group. No significant difference in lipid profile was present between normotensive (NT) and hypertensive (HT) CAD patients. Conclusion: Dyslipidemia is common among Egyptians with CAD. Lipid profile was influenced by age, gender, type of CAD, but not by the presence of HT. The high prevalence rate of risk factors particularly among young Egyptians is remarkable and can explain the epidemic of CAD among Egyptians. (C) 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码:79 / 85
页数:7
相关论文
共 50 条
  • [1] Lipid profile in patients with coronary artery disease
    Dana, P
    Zdrenghea, D
    Muste, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 115 - 115
  • [2] Lipid profile in patients with coronary artery disease
    Haddad, FH
    Omari, AA
    Shamailah, QM
    Malkawi, OM
    Shehab, AI
    Mudabber, HK
    Shubak, MK
    SAUDI MEDICAL JOURNAL, 2002, 23 (09) : 1054 - 1058
  • [3] Abnormal Lipid Profile in Patients with Coronary Artery Disease
    Cheema, Hina Aslam
    Ijaz, Farrukh
    Zahra, Maliha Tul
    Memon, Abeer
    Hussain, Wajid
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (04): : 1206 - 1208
  • [4] Lipid profile in COPD patients with coronary artery disease comorbidity
    Krakhmalova, Olena
    Hetman, Olena
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [5] Coronary artery ectasia in Egyptian patients with coronary artery disease
    Waly, HM
    Elayda, MA
    Lee, VV
    El-Said, G
    Reul, GJ
    Hall, RJ
    TEXAS HEART INSTITUTE JOURNAL, 1997, 24 (04): : 349 - 352
  • [6] Risk profile and lipid peroxidation in young patients with coronary artery disease
    Kocas, C.
    Abaci, O.
    Ozkan, A. A.
    Kaya, A.
    Okcun, B.
    Kilickesmez, K.
    Ersanli, M.
    Yigit, Z.
    Gurmen, T.
    HYPERTENSION, 2008, 52 (04) : 762 - 762
  • [7] A physiotherapeutic programme in patients with diabetes and coronary artery disease: management of lipid profile
    Marques-Sule, E.
    Ruescas-Nicolau, A.
    Querol-Fuentes, F.
    Mesa-Rico, R.
    Timonet-Andreu, E.
    Canca-Sanchez, J. C.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2014, 13 : S44 - S45
  • [8] Association of Lipid Profile With Total Occlusion in Patients With Established Coronary Artery Disease
    Li, Tianyu
    Yuan, Jinqing
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B236 - B237
  • [9] Lipid profile in the acute phase of coronary artery disease
    Batalla, A
    Reguero, JR
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 80 (2-3) : 265 - 265
  • [10] Correlation of antioxidants with lipid peroxidation and lipid profile in patients suffering from coronary artery disease
    Gupta, Shailja
    Sodhi, Sakshi
    Mahajan, Vivek
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (08) : 889 - 894